Profound Medical Q1 2026 Earnings
Analysis based on 6 articles · First reported Apr 16, 2026 · Last updated Apr 16, 2026
The announcement of first quarter 2026 financial results by Profound Medical will provide investors with insights into the company's performance and future outlook. The subsequent conference call will allow for further discussion on business developments, potentially influencing investor sentiment and stock price for Profound Medical.
Profound Medical, a commercial-stage medical device company, is set to announce its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Following the announcement, Profound Medical management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments. Profound Medical specializes in AI-powered, MRI-guided, incision-free therapies for diseased tissue, with flagship platforms like TULSA-PRO for prostate therapy and Sonalleve for pain palliation and gynecologic conditions. The company's technologies are approved in major global markets including the United States, Europe, and Canada.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard